Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.890
+0.030 (0.62%)
At close: Jan 30, 2026, 4:00 PM EST
4.960
+0.070 (1.43%)
After-hours: Jan 30, 2026, 7:52 PM EST
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 253 employees as of December 31, 2024. The number of employees decreased by 14 or -5.24% compared to the previous year.
Employees
253
Change (1Y)
-14
Growth (1Y)
-5.24%
Revenue / Employee
$1,339,870
Profits / Employee
$112,842
Market Cap
795.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 253 | -14 | -5.24% |
| Dec 31, 2023 | 267 | 48 | 21.92% |
| Dec 31, 2022 | 219 | 0 | - |
| Dec 31, 2021 | 219 | -13 | -5.60% |
| Dec 31, 2020 | 232 | -85 | -26.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,788 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 2,028 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 869 |
| Pacira BioSciences | 790 |
| Cronos Group | 459 |
| Kamada | 420 |
IRWD News
- 4 weeks ago - Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance - Business Wire
- 2 months ago - Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 - Seeking Alpha
- 2 months ago - Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance - Business Wire
- 3 months ago - Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta - Accesswire
- 6 months ago - Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance - Business Wire
- 9 months ago - Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire
- 9 months ago - Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire
- 10 months ago - Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - Business Wire